Download presentation
1
Case Studies in Infrahyoid Neck
Nicholas A. Koontz, M.D. Neuroradiology Fellow, University of Utah
2
Financial Disclosures
3
But first… Please direct your smart phone, tablet, or laptop’s browser to:
4
Objectives Review Infrahyoid Neck Anatomy Cases, Cases, Cases
Deep Spaces Nodal Stations Cases, Cases, Cases Tackle challenging cases Develop an appropriate differential diagnosis Identify useful discriminators Multiple choice questions
5
Anatomy
6
Anatomic Spaces of Infrahyoid Neck
Visceral Space Carotid Space Retropharyngeal Space Perivertebral Space Posterior Cervical Space
7
Infrahyoid Lymph Node Stations
8
Cases
9
Case 1 65 year-old woman with neck pain, palpable lump
10
Red Arrow = Enlarged, heterogeneous attenuation/enhancing thyroid mass with internal calcs
Yellow Arrow = Indistinct & infiltrating margins, effacement of IJV Green Arrow = Cystic level III met
11
Red Arrow = Intrathyroidal calcs
12
Red Arrow = Punctate calc associated with necrotic level III node
Orange Arrows = Additional solid adenopathy
13
Differential Diagnosis
Differentiated Thyroid Ca Medullary Thyroid Ca Anaplastic Thyroid Ca Thyroid NHL Multinodular Goiter
14
Most Likely Diagnosis Differentiated Thyroid Ca (DTCa) Age & Sex
Ill-defined Infiltrating, invasive Mixed solid/cystic Intra-thyroidal Calcs Intra-nodal Adenopathy Some solid Some cystic Punctate calcs
16
Question 1 Which of the following is a TRUE statement?
A. Follicular is the most common subtype of DTCa B. Hematogenous spread is more commonly associated with Papillary carcinoma C. The peak incidence of DTCa is seen in women in the third or fourth decade D. Rising free T4 is a clinical marker for disease recurrence
17
Question 1 Which of the following is a TRUE statement?
A. Follicular is the most common subtype of DTCa B. Hematogenous spread is more commonly associated with Papillary carcinoma C. The peak incidence of DTCa is seen in women in the third or fourth decade D. Rising free T4 is a clinical marker for disease recurrence Papillary = 80%, Follicular = 10% Papillary nodal, follicular hematogenous 3x more common in women, peak incidence in 20s to 30s Thyroglobulin = clinical marker of recurrence
18
DTCa Companion Cases
19
1) 75 year-old-woman, neck lump
Yellow Arrow = Heterogeneous thyroid mass Red Arrows = Punctate calcs within thyroid mass and enlarged superior mediastinal node
20
2) 48 year-old-woman, enlarging mass
Red Arrow = Heterogeneous thyroid mass with punctate & stippled calcs Green Arrows = Heterogeneously enhancing/cystic adenopathy
21
3) Nodal Manifestations of DTCa
Green Arrow = Cystic, necrotic adenopathy Red Arrow = Punctate calc in LN Blue Arrow = High T1 SI node (thyroglobulin) Yellow Arrow = Low T1 SI node
22
4) 30 year-old-woman, adenoma
Yellow Arrow = Circumscribed, heterogeneous attenuation/enhancment thyroid mass Red Arrow = Effaced subglottic & tracheal airway Blue Arrow = Prominent solid jugulodigastric node, maintained reniform shape. No calcs or necrosis. Magnified Cor CECT of LN
23
Case 2 55 year-old-woman with right neck mass, cough
24
Yellow Arrows = Heterogeneous attenuation LNs
25
Differential Diagnosis
H&N SCCa Metastatic Nodes Systemic Nodal Metastases Thyroid Ca Metastatic Nodes HL or NHL Nodes Granulomatous Lymph Nodes Reactive Adenopathy
26
Most Likely Diagnosis Systemic Nodal Mets Central low-density/necrosis
Infrahyoid (level IV) location H&N primary SCCa more commonly levels II & III Non-calcified Sarcoid, DTCa often Ca++ Central low-density/necrosis HL, NHL, & reactive nodes usually solid, but can be low-density
27
Use Everything at Your Disposal
“I’ll tell you right now – that ain’t normal.” -- Rick Wiggins
30
Question 2 Which of the following is MOST suggestive of systemic nodal metastases in the neck? A. Enlarged suprahyoid (level I or II) node B. Enlarged left supraclavicular lymph node C. Centrally necrotic lymph node D. Calcification within an enlarged cervical node
31
Question 2 Which of the following is MOST suggestive of systemic nodal metastases in the neck? A. Enlarged suprahyoid (level I or II) node B. Enlarged left supraclavicular lymph node C. Centrally necrotic lymph node D. Calcification within an enlarged cervical node Systemic nodal mets infrahyoid > suprahyoid “Signal” node. Central necrosis nonspecific, can be from H&N SCCa, systemic mets, suppurative nodes, etc. Calcs may be seen in DTCa, adenoCa mets.
32
Companion Case
33
25-year-old man with neck mass
Yellow Arrows = Heterogeneous low attenuation supraclavicular LNs and axial adenopathy
34
HL with “Signal” Node AKA Virchow node
Isolated left supraclavicular adenopathy look to the chest & abdomen for primary Most HL patients present with neck nodes Concurrent mediastinal nodes common Rarely extranodal H&N disease M > F Peak incidence in mid-20s
36
Question 3 Which of the following is a TRUE statement?
A. HL is more common than NHL B. Extranodal disease favors HL over NHL C. Imaging can reliably differentiate NHL from HL D. HL has an earlier peak incidence than NHL
37
Question 3 Which of the following is a TRUE statement?
A. HL is more common than NHL B. Extranodal disease favors HL over NHL C. Imaging can reliably differentiate NHL from HL D. HL has an earlier peak incidence than NHL NHL is more common than HL (HL = 14% of lymphoma) HL is RARELY extranodal (<1%), NHL extranodal in 30% Imaging is good for staging disease, but poor at differentiating HL from NHL HL median age = 27, NHL median age = 53
38
Case 4 55-year-old woman with known thyroid nodules, reportedly benign – surveillance US
39
Longitudinal Transverse Power Doppler
40
Prior biopsy reported benign
41
Yellow Arrows = Low-density, poorly enhancing carotid space mass
42
Differential Diagnosis
Congenital lesion Lymphatic malformation Venolymphatic malformation Venous malformation 3rd Branchial cleft cyst Neurofibroma Schwannoma Malignant Lymph node Carotid artery Pseudoaneurysm
43
Most Likely Diagnosis Congenital lesion Why not a NST?
Lymphatic malformation Benign, circumscribed No flow on US Demonstrably separate from IJV and CCA Venolymphatic malformation Possible, but would have essentially no venous component Why not a NST?
44
Carotid Space Nerve Sheath Tumor
Image c/o Lauren Ladd, M.D. Pros Cons Location Size Morphology Low Density Echogenicity Lack of vascularity
45
CS Nerve Sheath Tumor Comparison
CS Schwannoma CS Neurofibroma Shape Fusiform Ovoid or fusiform (***unless plexiform) Margins Circumscribed Circumscribed (***unless plexiform) Size 2 - 8 cm 2 - 5 cm M:F Male predominance Female Predominance NECT Isodense to muscle Hypodense CECT Uniform enhancement, rare low density Poorly enhancing T1WI -C Variable, no flow voids Isointense to muscle T1WI +C Marked uniform enhancement Homogeneous or patchy enhancement T2WI Hyperintense to muscle, +/- intratumoral cysts Very hyperintense, "target sign"
47
Question 4 Which of the following is a FALSE statement?
A. Most lymphatic malformations are diagnosed before age 2 B. Lymphatic malformations can be acquired C. Lymphatic malformations have no malignant potential D. Microcystic lymphatic malformations are less likely to recur than macrocystic malformations
48
Question 4 Which of the following is a FALSE statement?
A. Most lymphatic malformations are diagnosed before age 2 B. Lymphatic malformations can be acquired C. Lymphatic malformations have no malignant potential D. Microcystic lymphatic malformations are less likely to recur than macrocystic malformations 90% diagnosed by age 2 In adults lymphatic malformations can be acquired think trauma. No malignant potential. LM can be micro or macro cystic – microcystic are more likely to recur than macrocystic.
49
Case 5 25-year-old man with enlarging neck mass, recent URI
50
Yellow Arrow = Thick walled, peripherally enhancing midline infrahyoid lesion just below hyoid
Red Arrow = Additional thick walled, peripherally enhancing midline lesion FOM
51
Yellow Arrow = same peripherally enhancing lesion in Cor
Cyan Arrow = corticated osseous defect in hyoid bone
52
Yellow Arrow = TGDC Red Arrow = FOM abscess
53
Same patient, 3 days prior
Yellow Arrow = Same TGDC, smaller, less enhancement Red Arrow = Blush of enhancement, no abscess
54
Differential Diagnosis
Thyroglossal Duct Cyst Lymphatic Malformation Mixed Laryngocele Necrotic Lymph Node Abscess Thyroid Ca Lymphatic malformation can look identical history is your friend
55
Most Likely Diagnosis Infected Thyroglossal Duct Cyst with associated FOM Abscess Classic history Midline/paramidline infrahyoid Wall enhancement infected Round or ovoid Cyst No calcs or solid component
56
Thyroglossal Duct Cyst Key Points
Cystic remnant of TGD Lesion of the young Location 20-25% = Suprahyoid 50% = Hyoid 25% = Infrahyoid Infrahyoid typically embedded in strap muscles “claw” sign Wall enhancement if infected < 1% will develop Thyroid Ca
58
Question 5 Which of the following is a TRUE statement?
A. Thyroglossal duct cyst is the most common congenital neck mass B. Thyroglossal duct cysts are always midline structures C. The most common malignancy to develop in a thyroglossal duct cyst is medullary thyroid Ca D. Treatment of thyroglossal duct cyst is typically needle aspiration
59
Question 5 Which of the following is a TRUE statement?
A. Thyroglossal duct cyst is the most common congenital neck mass B. Thyroglossal duct cysts are always midline structures C. The most common malignancy to develop in a thyroglossal duct cyst is medullary thyroid Ca D. Treatment of thyroglossal duct cyst is typically needle aspiration True. Off-midline below the hyoid Well-differentiated thyroid Ca, usually papillary Sistrunk procedure (cyst, tract, and branch excision requiring removal of the central hyoid bone)
60
TGD Cyst Companion Cases
61
1) 50-year-old man with neck mass
TGD Cyst. High density = heme, protein.
62
TGD Cyst. Suprahyoid/BOT.
2) Young girl, dysphagia TGD Cyst. Suprahyoid/BOT.
63
TGD Cyst Thyroid Ca. Enhancing nodule. Coarse calc. Nodal Met.
3) Enlarging neck mass TGD Cyst Thyroid Ca. Enhancing nodule. Coarse calc. Nodal Met.
64
4) Ectopic Thyroid
65
Case 6 31-year-old woman with difficult intubation during elective surgery
66
Yellow Arrows = Circumscribed, heterogeneous submucosal mass originating in subglottic larynx. No deep invasion.
67
“I’ll tell you right now – that ain’t normal.”
-- Rick Wiggins Green Arrow = Low density mass at skull bass, carotid space Red Arrows = Similar density L infraclavicular masses
68
Ax T1WI +C FS Ax T1WI +C FS Cor T1WI +C FS Ax T2WI FS Ax T2WI FS
Yellow Arrows = Subglottic larynx mass Red Arrows = Infraclavic masses Green Arrows = CS mass Cor T1WI +C FS Ax T2WI FS Ax T2WI FS
69
Differential Diagnosis
NF1 NF2 Schwannomatosis Laryngeal SCCa with Mets Chondrosarcoma with Mets Intrinsic vs Extrinsic causes
71
Ax T2WI FS Ax T1WI +C FS Normal IACs
72
Most Likely Diagnosis Schwannomatosis No matrix calcification
Morphology & Margins SCCa infiltrative/invasive Distribution CS + Brachial plexus NST NORMAL IACs NF2 less likely Age NF1 = 1st decade NF2 = 2nd decade Schwannomatosis = 3-4th decades No matrix calcification MR signal NST Intrinsic vs Extrinsic causes
74
Question 6 Which of the following is a TRUE statement?
A. Schwannomas grow centrally within an involved nerve B. Schwannomatosis patients demonstrate a normal life expectancy C. Schwannomas arise from pericytes in the nerve sheath D. Schwannomatosis is more common than NF1
75
Question 6 Which of the following is a TRUE statement?
A. Schwannomas grow centrally within an involved nerve B. Schwannomatosis patients demonstrate a normal life expectancy C. Schwannomas arise from pericytes in the nerve sheath D. Schwannomatosis is more common than NF1 Eccentric to affected nerve. Normal life expectancy, unlike NF2 Arive from Schwann cells, not pericytes NF1 > NF2 ~ Schwannomatosis
76
Schwannomatosis Key Points
Multiple nonintradermal schwannomas WITHOUT vestibular nerve involvement Separate disease entity from NF2 Different gene mutation SMARCB1 vs. NF2 Later onset 4th decade vs. 2nd decade Normal life expectancy (unlike NF2) Pain >> neurologic deficits (unlike NF2) Similar incidence to NF2 (~ 1/40,000)
77
Infrahyoid Neck Conclusion
Several deep spaces & nodal stations Wide variety of pathology Look for useful discriminators: Age History Deep space of origin
78
Thanks
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.